|
Session 84
Poster Abstracts
Miscellaneous Immune-Based Therapeutic Approaches to HIV Infection
Tuesday, 1:30 - 3:30 pm
Poster Hall |
490
 |
Therapy of SHIV-infected Macaques with Antisense DNA of IL-4
Navneet Dhillon*1, S Dhillon1, Y Chebloune1, I Adany1, Z Li1, F Villinger2, O Narayan1, and S Buch1
1Kansas Univ Med Ctr, Kansas City, US and 2Emory Univ, Atlanta, GA, US |
| 491 |
IL-21: A Novel Regulator of Cytotoxic Potential in CD8 T Cells of HIV-infected Patients
Lesley White*1, N Strbo1, H Liu1, M Kolber1, W Kindsvogel2, and S Pahwa1
1Univ of Miami, Miller Sch of Med, FL, US and 2Zymogenetics, Seattle, WA, US |
492
|
Natural Killer Cells as Targets for Immune-based Intervention in HIV Disease
Gabriella d'Ettorre*1, M Andreotti2, C Andreoni1, L Zaffiri1, S Antonucci1, S Vella2, V Vullo1, and C Mastroianni1
1La Sapienza Univ, Rome, Italy and 2Inst Superiore di Sanità, Rome, Italy |
| 493 |
Decreased FoxP3 Expression in CD4+CD25+ T Cells from HIV-1-infected Patients following IL-2 Therapy and Interruption of HAART
Sarah Wynne*, V Thaker, C Keh, J Shen, C Rehm, R Davey, H Lane, and I Sereti
NIAID, NIH, DHHS, Bethesda, MD, US |
| 494 |
Efficacy of Recombinant Interleukin-2 in Patients with Advanced HIV-1 Infection and Blunted Immune Response to HAART
Manel Crespo*, I Caragol, V Falcó, E Ribera, S Villar Del Saz, A González, I Ocaña, and A Pahissa
Vall d'Hebron's Hosp, Barcelona, Spain |
| 495 |
Effects of Recombinant Human Growth Hormone on HIV-1-specific T Cell Responses, Thymic Output and Proviral DNA in Patients on ART: 48-Week Follow-up
N Imami1, Catherine Burton*1, G Moyle2, B Gazzard2, and F Gotch1
1Imperial Coll, London, UK and 2Chelsea and Westminster Hosp, London, UK |
| 496 |
Effect of Genetic Host Factors on Treatment Success in HIV-1-infected Patients: Identification of Responders and Non-responders by GNAS Genotyping
Norbert Brockmeyer*1, G Faetkenheuer2, S Staszewski3, H Klinker4, J Rockstroh5, A Potthoff1, W Siffert6, and ESPRIT Study Group and Competence Network HIV/AIDS
1St Josef Hosp, Univ of Bochum, Germany; 2Univ Hosp Cologne, Germany; 3Univ Hosp Frankfurt, Germany; 4Univ Hosp Wuerzburg, Germany; 5Univ Hosp Bonn, Germany; and 6Univ of Essen, Germany |
497
|
Interleukin-15 Enhances the Natural Killer Activity According to HAART Suppression of HIV-1 Replication
Mauro Andreotti*1, G d'Ettorre2, C Andreoni2, M Mancini1, S Antonucci2, M Giuliano1, S Vella1, V Vullo2, and C Mastroianni2
1Inst Superiore di Sanità, Rome, Italy and 2Univ La Sapienza, Rome Italy |
|
